NCT04922632

Brief Summary

The United States is battling dual pandemics: healthcare provider (HCP) exhaustion and COVID-19. The COVID-19 pandemic death toll has surpassed 595,000 and continues to climb as the worldwide outbreak continues. Moreover, we have yet to understand the health impacts of "long-COVID". As evidenced by the national burnout epidemic in HCPs, persistent workplace stress not only impacts personal provider wellbeing, but also influences effective practice and patient outcomes. To address this need, we propose a 4-year, multi-site, four-arm parallel-group randomized clinical trial (RCT) comparing 2 non-pharmacological interventions: Transcendental Meditation (TM) and Experience Resolution Methodology (ERM) to Treatment as Usual (TAU). Participation in this study lasts up to 24 months for enrolled participants and is considered minimal risks.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
212

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 8, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 10, 2021

Completed
9 months until next milestone

Study Start

First participant enrolled

February 21, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 12, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 12, 2023

Completed
Last Updated

April 21, 2023

Status Verified

April 1, 2023

Enrollment Period

1.1 years

First QC Date

June 8, 2021

Last Update Submit

April 19, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in resilience as measured by the Connor-Davidson Resilience Scale-25

    The Connor-Davidson Resilience scale (CD-RISC) comprises of 25 items, each rated on a 5-point scale (0-4), with higher scores reflecting greater resilience

    Baseline to 3 months

Secondary Outcomes (6)

  • Change in burnout as measured by the Maslach Burnout Inventory (MBI).

    Baseline to 3 months

  • Change in depression as measured by the Patient Health Questionnaire-9 (PHQ-9).

    Baseline to 3 months

  • Change in psychological distress as measured by the Subject Units of Distress Scales (SUDS).

    Baseline to 3 months

  • Change in quality of life as measured by the Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form (Q-LES-Q-SF).

    Baseline to 3 months

  • Change in PTSD symptom severity as measured by the Post-Traumatic Stress Disorder (PTSD) checklist-5 (PCL-5).

    Baseline to 3 months

  • +1 more secondary outcomes

Study Arms (4)

Transcendental Medication (TM)

EXPERIMENTAL

Transcendental Meditation (TM): a mind-body program that allows the participant to experience progressively quieter, less excited states of mental activity, with growing experience of restful alertness in mind and body.

Behavioral: Transcendental Meditation (TM)

Experience Resolution Methodology (ERM)

EXPERIMENTAL

Experience Resolution Methodology (ERM): is a specific, protocolized coaching method that aims to maximize an individual's performance, professional development and well-being by recognizing and resolving subjective stress associated with specific situations, circumstances, events or experiences.

Behavioral: Experience Resolution Methodology (ERM)

TM+ERM

EXPERIMENTAL

Transcendental Meditation (TM) and Experience Resolution Methodology (ERM): an integrative method using both TM and ERM coaching with ERM with the aim of achieving an overall restful, alertness in mind and body and maximizing performance, professional development and well-being.

Behavioral: Transcendental Meditation (TM) and Experience Resolution Methodology (ERM)

Treatment As Usual (TAU)

ACTIVE COMPARATOR

Treatment As Usual (TAU): is the existing Duke Health \& Well-being services, such as the availability of acupuncture, integrative health coaching, integrative nutrition and weight management, personal exercise training, massage therapy, yoga therapy, mindfulness-based stress reduction (MBSR), experiencing mindfulness, group fitness classes, gentle yoga, or chair yoga, as well as additional resources such as Personal Assistance Services (PAS).

Behavioral: Treatment As Usual (TAU)

Interventions

TM is a mind-body program that allows the participant to experience progressively quieter, less excited states of mental activity, with growing experience of restful alertness in mind and body.

Transcendental Medication (TM)

ERM is a specific, protocolized coaching method that aims to maximize an individual's performance, professional development and well-being by recognizing and resolving subjective stress associated with specific situations, circumstances, events or experiences.

Experience Resolution Methodology (ERM)

TM + ERM is an integrative method using both TM and ERM coaching with ERM with the aim of achieving an overall restful, alertness in mind and body and maximizing performance, professional development and well-being.

TM+ERM

TAU is the existing Duke Health \& Well-being services, such as the availability of acupuncture, integrative health coaching, integrative nutrition and weight management, personal exercise training, massage therapy, yoga therapy, mindfulness-based stress reduction (MBSR), experiencing mindfulness, group fitness classes, gentle yoga, or chair yoga, as well as additional resources such as Personal Assistance Services (PAS).

Treatment As Usual (TAU)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Full-time HCPs
  • A score of \>= 5 on the Subjective Units of Distress Scale (SUDS) at baseline visit.
  • Willingness to address burnout symptoms by non-pharmacological means.
  • Willingness to wear the provided wearable device (e.g., Apple, Empatica, and/or eSense) at the designated study visits and/or determined coaching sessions, as well as wear an Apple device, if eligible to receive an Apple watch, from baseline for the duration of the study (up to 24 months).
  • Willingness to download the PatternHealth app on personal device.

You may not qualify if:

  • Addition or change in dosage of psychotropic medications, beta-blockers, or anti-epileptic medications within the last 2 months
  • HCPs may re-present for screening again after 2 months has passed since their last change in the medication categories listed that previously excluded them for re-evaluation for study eligibility.
  • Current suicidal or homicidal ideation at the time of screening, as defined by the C-SSRS.
  • Prior instruction in the Transcendental Meditation (TM) technique by a certified instructor.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Medical Center

Durham, North Carolina, 27710, United States

Location

MeSH Terms

Conditions

Burnout, ProfessionalCaregiver BurdenCOVID-19

Interventions

MeditationTherapeutics

Condition Hierarchy (Ancestors)

Occupational StressOccupational DiseasesBurnout, PsychologicalStress, PsychologicalBehavioral SymptomsBehaviorPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesSpiritual TherapiesRelaxation TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Sangeeta Joshi, MD

    Duke University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A 4-year, multi-site, four-arm parallel-group randomized clinical trial (RCT).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 8, 2021

First Posted

June 10, 2021

Study Start

February 21, 2022

Primary Completion

March 12, 2023

Study Completion

March 12, 2023

Last Updated

April 21, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

De-identified data, post analysis may be shared with other researchers at scientific meetings and published within scientific journals.

Locations